Biomedical (BASIC)

Ended Definitive Contract Awarded Last action

Contract number
00261199209D261925516
Awardee
Awarding agency
Obligated
$31,705,192

Award facts

Contract value 5% obligated
  • $663,161,924.17 Current, with exercised options
  • $682,901,306.05 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 21 offers
Pricing
Cost Sharing
Place of performance
University City, MO 63130, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 103 -$384,387
Other Administrative Action 102 · Other functions plco/nlst follow-up and pathology phase -$461,962
Other Administrative Action 101 · Plco/nlst follow-up and pathology phase no cost extension $0
Funding Only Action 100 · Plco/nlst FY2010 funding $277,681
Supplemental Agreement for work within scope 99 · Plco pathology collection -- no-cost extension $0
Supplemental Agreement for work within scope 98 $0
Supplemental Agreement for work within scope 97 $0
Supplemental Agreement for work within scope 96 $0
Exercise an Option 95 $81,550
Supplemental Agreement for work within scope 94 $950,956
Other Administrative Action 93 $0
Other Administrative Action 92 $0
Funding Only Action 91 $530,010
Funding Only Action 90 $12,704
Supplemental Agreement for work within scope 89 $44,528
Exercise an Option 88 $44,163
Funding Only Action 87 $396,905
Funding Only Action 86 · Prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - screening centers $1,443,516
Additional Work (new agreement, FAR part 6 applies) 85 $21,765
Exercise an Option 84 $76,336
Other Administrative Action 83 $0
Funding Only Action 82 $759,255
Funding Only Action 81 $798,070
Change Order 80 $1,540
Supplemental Agreement for work within scope 79 $0
Other Administrative Action 78 $0
Supplemental Agreement for work within scope 77 $0
Funding Only Action 76 $101,622
Funding Only Action 75 $650,023
Funding Only Action 74 $1,846,793
Other Administrative Action 73 $0
Additional Work (new agreement, FAR part 6 applies) 72 $0
Supplemental Agreement for work within scope 71 $100,807
Supplemental Agreement for work within scope 70 $0
Funding Only Action 69 $525,646
Funding Only Action 68 $2,371,792
Funding Only Action 67 $117,381
Supplemental Agreement for work within scope 66 $67,857
Supplemental Agreement for work within scope 65 $2,334,429
Other Administrative Action 63 $0
Other Administrative Action 64 $0
Other Administrative Action 61 $0
Funding Only Action 62 $133,692
Supplemental Agreement for work within scope 60 $0
Supplemental Agreement for work within scope 59 $467,746
Supplemental Agreement for work within scope 58 $2,797,251
Supplemental Agreement for work within scope 57 $2,552,280
Supplemental Agreement for work within scope 56 $159,327
Supplemental Agreement for work within scope 55 $866,916
Supplemental Agreement for work within scope 53 $1,734,000
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

About this award

Written by GovTribe AI ·

This is a definitive federal contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to The Washington University (Washington University) in St. Louis, Missouri. The $682,901,306.05 cost-sharing contract is for biomedical research and development (R&D) work and does not have a set-aside designation.

As a prominent research institution, Washington University has extensive experience in conducting federal R&D for agencies like the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. In addition to this contract, the university receives significant grant funding, particularly from the NIH, for a wide range of biomedical and health sciences research projects. Washington University also holds an Indefinite Delivery Contract (IDC) vehicle with the Department of Veterans Affairs to provide specialized research training and mentoring services.

Quick answers

Who was awarded contract 00261199209D261925516?

00261199209D261925516 was awarded to The Washington University by National Cancer Institute (National Institutes of Health) on September 30, 1992.

How much is contract 00261199209D261925516 worth?

The government has obligated $31,705,192 on 00261199209D261925516. Its current value, with exercised options, is $663,161,924. Its potential value, with all options, is $682,901,306.

Was contract 00261199209D261925516 competed?

The extent of competition for 00261199209D261925516 was full and open competition. The government received 21 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login